Meyka Pro banner
Innovacell Inc.

Innovacell Inc. (504A.T) Stock Overview

Explore Innovacell Inc.’s financial performance, market position, analyst ratings, and future outlook.

504A.TJPX
HealthcareBiotechnology
¥545.00
¥34.00(5.87%)
Japanese Market opens in 10h 53m

Innovacell Inc. (504A.T)

Meyka AI Score

Z

Key Financials

Market Cap26.1B
P/E RatioN/A
EPS (TTM)$-68.41
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

504A.T Stock Analysis & Investment Overview (JPX)

Our AI-powered analysis of Innovacell Inc. (JPX: 504A.T) gives investors deep insight into how the stock performs on the JPX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Innovacell Inc.'s JPX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of 504A.T on the JPX shows an RSI of 46.55, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the JPX listing.

Key metrics behind Innovacell Inc.'s JPX-traded stock include a P/E ratio of N/A and a market capitalization of 26.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of 504A.T on the JPX.

Price Performance (JPX: 504A.T)

1-Day Change
N/A
5-Day Change
-4.30%
1-Month Change
23.72%
3-Month Change
-9.67%
6-Month Change
-42.10%
Year-to-Date (YTD) Change
-44.86%
1-Year Change
-44.86%
3-Year Change
-44.86%
5-Year Change
-44.86%
All-Time (Max) Change
-44.86%

Contact Information

NaN
MEGURO VILLA GARDEN 5F, Tokyo, TY, 141-0021

Company Facts

480 Employees
IPO DateFeb 24, 2026
CountryJP
Actively Trading

Frequently Asked Questions